Our Products / Product center
Product Introduction
01 Anti-tumor New Drug CM082
Malignant tumor has been the major disease threatening human life severely. Despite of certain curative effect of existing treatments, most of tumor patients are facing with limited time to live and lack of effectively curative drugs. It is necessary to develop new drugs to satisfy their demands. At present, a great majority of anti-tumor drugs in clinical treatment are featured by severe toxic and side effect, MDR and other problems.
Subject Recruitment
Clinical Research on Combination of CM082 and Everolimus for Advanced Kidney Cancer Treatment